Skip to main content
. Author manuscript; available in PMC: 2023 Nov 27.
Published in final edited form as: Head Neck. 2022 Apr 13;44(7):1509–1519. doi: 10.1002/hed.27043

Table 3:

Toxicities of Induction Chemotherapy

CTCAE Grade
3 4 5 Total
Neutropenia 2 3 0 5 (9%)
Diarrhea 4 0 0 4 (7%)
Nausea 4 0 0 4 (7%)
Vomiting 3 0 0 3 (5%)
Dehydration 2 0 0 2 (4%)
Hypokalemia 2 0 0 2 (4%)
Alanine aminotransferase increased 1 0 0 1 (2%)
Anemia 1 0 0 1 (2%)
Anorexia 1 0 0 1 (2%)
Decreased Glomerular Filtration Rate 0 1 0 1 (2%)
Hand-and-foot syndrome 1 0 0 1 (2%)
Hyponatremia 1 0 0 1 (2%)
Pneumonia 1 0 0 1 (2%)
Intracranial hemorrhage 0 0 1 1 (2%)
Mucositis oral 1 0 0 1 (2%)
Pruritus 1 0 0 1 (2%)
Rash 1 0 0 1 (2%)
Sepsis 0 1 0 1 (2%)
Thrombosis/thrombus/embolism 1 0 0 1 (2%)
Weight loss 1 0 0 1 (2%)
Laryngospasm 1 0 0 1 (2%)
Sudden Cardiac Arrest 0 0 1 1 (2%)

Includes all grade 3 or greater toxicities seen during induction chemotherapy and assessed by investigator to be possibly, probably, or definitely due to therapy